Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Allergan has received positive opinion from the Irish health authority for Botox (botulinum toxin type A) to treat urinary incontinence in patients with multiple sclerosis or spinal cord injury.
Subscribe to our email newsletter
The Irish Medicines Board for the management of urinary incontinence in adults with neurogenic detrusor overactivity’s (NDO) decision is supported by the results of Phase III programme evaluating Botox.
The trial results demonstrated that the targeted injections of Botox into the bladder muscle showed reduction in the involuntary contractions and increase bladder capacity.
Allergan president for Europe, Africa and the Middle East Douglas Ingram said their task now is to work closely with the national health authorities to secure the relevant national licenses so that they can bring this valuable treatment option to patients, as quickly as possible.